Article
Structural insight into the catalytic mechanism of gluconate 5-dehydrogenase from Streptococcus suis: Crystal structures of the substrate-free and quaternary complex enzymes
Article first published online: 2 DEC 2008
DOI: 10.1002/pro.32
Copyright © 2009 The Protein Society
Additional Information
How to Cite
Zhang, Q., Peng, H., Gao, F., Liu, Y., Cheng, H., Thompson, J. and Gao, G. F. (2009), Structural insight into the catalytic mechanism of gluconate 5-dehydrogenase from Streptococcus suis: Crystal structures of the substrate-free and quaternary complex enzymes. Protein Science, 18: 294–303. doi: 10.1002/pro.32
Publication History
- Issue published online: 30 JAN 2009
- Article first published online: 2 DEC 2008
- Manuscript Accepted: 6 NOV 2008
- Manuscript Revised: 3 NOV 2008
- Manuscript Received: 19 SEP 2008
Funded by
- The National Basic Research Program (973), Ministry of Science and Technology of China (MOST). Grant Number: 2005CB523001
- National Key Technologies R&D Program, Ministry of Science and Technology of China (MOST). Grant Number: 2006BAD06A04
- National Natural Science Foundation of China (NSFC). Grant Numbers: 30770024, 30525010
- Intramural Research Program of the NIDCR, National Institutes of Health
Keywords:
- Streptococcus suis serotype 2;
- gluconate 5-dehydrogenase (Ga5DH);
- quaternary complex;
- SDR enzymes;
- catalytic mechanism
Abstract
Gluconate 5-dehydrogenase (Ga5DH) is an NADP(H)-dependent enzyme that catalyzes a reversible oxidoreduction reaction between D-gluconate and 5-keto-D-gluconate, thereby regulating the flux of this important carbon and energy source in bacteria. Despite the considerable amount of physiological and biochemical knowledge of Ga5DH, there is little physical or structural information available for this enzyme. To this end, we herein report the crystal structures of Ga5DH from pathogenic Streptococcus suis serotype 2 in both substrate-free and liganded (NADP+/D-gluconate/metal ion) quaternary complex forms at 2.0 Å resolution. Structural analysis reveals that Ga5DH adopts a protein fold similar to that found in members of the short chain dehydrogenase/reductase (SDR) family, while the enzyme itself represents a previously uncharacterized member of this family. In solution, Ga5DH exists as a tetramer that comprised four identical ∼29 kDa subunits. The catalytic site of Ga5DH shows considerable architectural similarity to that found in other enzymes of the SDR family, but the S. suis protein contains an additional residue (Arg104) that plays an important role in the binding and orientation of substrate. The quaternary complex structure provides the first clear crystallographic evidence for the role of a catalytically important serine residue and also reveals an amino acid tetrad RSYK that differs from the SYK triad found in the majority of SDR enzymes. Detailed analysis of the crystal structures reveals important contributions of Ca2+ ions to active site formation and of specific residues at the C-termini of subunits to tetramer assembly. Because Ga5DH is a potential target for therapy, our findings provide insight not only of catalytic mechanism, but also suggest a target of structure-based drug design.

1469-896X/asset/olbannerleft.gif?v=1&s=d218899ae53b2862ab119790ed504b8d72122fb3)
1469-896X/asset/olbannerright.gif?v=1&s=59470eb9a1d9b7b13b1be75e9445e6c46ee2214f)
